TYRA
NASDAQ
US
Tyra Biosciences, Inc. - Common Stock
$39.61
▲ +$1.33
(+3.47%)
Vol 1.0M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.4B
ROE
-35.8%
D/E
0.00
Beta
1.07
52W
$6–$26
Wall Street Consensus
18 analysts · Apr 20268
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating
Price Chart
Similar Stocks
SNDX
Syndax Pharmaceuticals Inc
$1.8B
DAWN
Day One Biopharmaceuticals Inc
$956.9M
ADMA
ADMA Biologics Inc
P/E 20.7
$4.3B
RARE
Ultragenyx Pharmaceutical Inc
$2.2B
CLDX
Celldex Therapeutics Inc
$1.8B
AGIO
Agios Pharmaceuticals Inc
$1.6B
SLNO
Soleno Therapeutics Inc
$2.5B
STOK
Stoke Therapeutics Inc
P/E 44.2
$1.8B
VRDN
Viridian Therapeutics Inc
$3.0B
CAPR
Capricor Therapeutics Inc
$1.6B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.54 | $-0.57 | $-0.03 |
| Sep 2025 | $-0.51 | $-0.50 | +$0.01 |
| Jun 2025 | $-0.54 | $-0.47 | +$0.07 |
| Mar 2025 | $-0.50 | $-0.47 | +$0.03 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -31.8% | -27.5% | -31.8% | -31.8% | -31.8% | -35.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 21.94 | 22.78 | 21.94 | 21.94 | 21.94 | 17.71 |
Key Ratios
ROA (TTM)
-33.6%
P/B
2.0
EPS (TTM)
$-1.88
CF/Share
$-1.38
52W High
$26.34
52W Low
$6.42
$6.42
52-Week Range
$26.34
How does TYRA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TYRA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.1
▼
17%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TYRA profitability vs Biotechnology peers
ROE
-35.8%
▲
47%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-33.6%
▲
28%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
TYRA financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
17.7
▲
299%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.1
▲
11%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
TYRA fundamentals radar
TYRA
Peer median
Industry
TYRA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TYRA vs peers: key metrics
Latest News
No related news yet